Circulating Tumor Material in Colorectal Cancer and Melanoma
| Status: | Recruiting |
|---|---|
| Conditions: | Colorectal Cancer, Skin Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/10/2018 |
| Start Date: | August 2016 |
| Contact: | Mark O'Hara, MD |
| Email: | PennCancerTrials@emergingmed.com |
| Phone: | 855-216-0098 |
Protocol to Permit the Acquisition of Circulating Tumor Material in Colorectal Cancer and Melanoma
Observational study to allow the collection of blood and medical information to evaluate the
role of circulating tumor material in patients with colorectal cancer and melanoma
role of circulating tumor material in patients with colorectal cancer and melanoma
Inclusion Criteria:
- The subject must be a patient at the Hospital of the University of Pennsylvania
1. Patients with presumed stage II, III, or IV colorectal cancer with planned
surgical resection of either the primary tumor or metastatic lesion(s) being
evaluated at the Hospital of the University of Pennsylvania
2. Patients with histologically confirmed melanoma stage IIb, IIc, IIIa, IIIb, or
IIIc/IV scheduled for surgical resection being evaluated at the Hospital of the
University of Pennsylvania.
- The subject must be able to provide informed consent or have an acceptable surrogate
capable of giving consent on the subject's behalf.
- The subject must be 18 years of age or older.
Exclusion Criteria:
- The subject is not able to provide informed consent.
We found this trial at
1
site
3400 Civic Center Blvd
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-6065
Principal Investigator: Mark O'Hara, MD
Phone: 855-216-0098
Abramson Cancer Center of the University of Pennsylvania The Abramson Cancer Center of the University...
Click here to add this to my saved trials
